Showing results (61-70 of 136) with videos related to
Sort By:
Pageof 14
Experimental & Molecular Medicine|November 7, 2025
Single-cell transcriptomics of the myeloid milieu reveals an angiogenic niche in triple-negative breast cancerYechan Choi, Minkyu Shim, Suhn Hyung Kim, et al.Plos One|March 22, 2017
The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbiditiesJaihong Han, Han-Byoel Lee, Eun-Shin Lee, et al.International Journal of Surgery (London, England)|March 15, 2024
Dynamic insights into infection risk over time in two-stage implant-based breast reconstruction: a retrospective cohort studyJeong Hyun Ha, Seoin Ahn, Hong-Kyu Kim, et al.BMC Cancer|May 6, 2020
NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasisSo-Hyun Yoon, Hoe Suk Kim, Ryong Nam Kim, et al.Journal of Breast Cancer|July 9, 2015
Risk Factors Associated with Distant Metastasis and Survival Outcomes in Breast Cancer Patients with Locoregional RecurrenceSoojin Park, Wonshik Han, Jongjin Kim, et al.Scientific Reports|February 3, 2021
Intensity of metastasis screening and survival outcomes in patients with breast cancerJong-Ho Cheun, Jigwang Jung, Eun-Shin Lee, et al.Journal of Breast Cancer|February 26, 2021
Association between Number of Retrieved Sentinel Lymph Nodes and Breast Cancer-related LymphedemaHong Kyu Kim, Young Wook Ju, Jun Woo Lee, et al.Journal of Breast Cancer|April 30, 2024
Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent ResponseJai Min Ryu, Hyunjun Lee, Wonshik Han, et al.European Radiology|January 31, 2018
Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumourSoo-Yeon Kim, Nariya Cho, Sung Ui Shin, et al.Breast Cancer Research and Treatment|January 3, 2021
Clinical significance of HER2 status in T1bN0 breast cancer: a nationwide study from the Korean Breast Cancer SocietyYoung-Joon Kang, Se Jeong Oh, Hoon Choi, et al.Pageof 14